全文获取类型
收费全文 | 3570篇 |
免费 | 208篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 62篇 |
妇产科学 | 67篇 |
基础医学 | 500篇 |
口腔科学 | 121篇 |
临床医学 | 221篇 |
内科学 | 941篇 |
皮肤病学 | 109篇 |
神经病学 | 319篇 |
特种医学 | 199篇 |
外科学 | 480篇 |
综合类 | 25篇 |
预防医学 | 315篇 |
眼科学 | 83篇 |
药学 | 147篇 |
中国医学 | 11篇 |
肿瘤学 | 166篇 |
出版年
2024年 | 2篇 |
2023年 | 31篇 |
2022年 | 69篇 |
2021年 | 134篇 |
2020年 | 74篇 |
2019年 | 103篇 |
2018年 | 117篇 |
2017年 | 80篇 |
2016年 | 94篇 |
2015年 | 124篇 |
2014年 | 166篇 |
2013年 | 180篇 |
2012年 | 284篇 |
2011年 | 274篇 |
2010年 | 166篇 |
2009年 | 134篇 |
2008年 | 242篇 |
2007年 | 267篇 |
2006年 | 265篇 |
2005年 | 206篇 |
2004年 | 214篇 |
2003年 | 186篇 |
2002年 | 157篇 |
2001年 | 32篇 |
2000年 | 27篇 |
1999年 | 20篇 |
1998年 | 33篇 |
1997年 | 15篇 |
1996年 | 16篇 |
1995年 | 10篇 |
1994年 | 8篇 |
1993年 | 4篇 |
1992年 | 6篇 |
1991年 | 6篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 2篇 |
1976年 | 3篇 |
1969年 | 1篇 |
1963年 | 2篇 |
1962年 | 1篇 |
1956年 | 1篇 |
1945年 | 1篇 |
排序方式: 共有3796条查询结果,搜索用时 15 毫秒
71.
Lopez-Espejo Mauricio A. Nuñez Alicia C. Moscoso Odalie C. Escobar Raul G. 《Journal of autism and developmental disorders》2021,51(12):4704-4710
Journal of Autism and Developmental Disorders - We conducted a cross-sectional study to explore whether clinical characteristics and autism diagnostic-traits severity are associated with... 相似文献
72.
Juan David Farfán-Albarracín Cristina Lorena Ramírez-Sierra Oscar Mauricio Espitia Segura Sofy Helena Pérez Hugo Andrés Téllez Prada María Camila Rueda Rodríguez Ingrid Lemus Espitia Ana Maritza Bedoya 《Brain & development》2021,43(1):63-68
IntroductionThe ratio of cerebrospinal fluid (CSF) glucose and blood glucose is of major relevance, conducting to the diagnosis of hypoglycorrhachia, which is a sign of neuroinfection, as well as a number of neurological diseases of genetic or neoplastic etiology. Glucose in capillary sample (glucometry) is a low cost, readily available technique, as compared to venous glucose. This study aims to compare glucometry to venous glucose in the diagnosis of hypoglycorrhachia in pediatric population.MethodsProspective cross-sectional study based on data obtained from lumbar punctures in the period from February 2017 to January 2019 in a specialized pediatric institution in Colombia.Results97 patients were analyzed, aged 1 month to 17 years old, mean 7.67 years, 52 (53.61%) were female. 26 (26.8%) were diagnosed with hypoglycorrhachia. Pearson correlation coefficient for absolute venous and capillary glucose was 0.54, and 0.55 for the ratios of CSF glucose/venous glucose and CSF glucose/glucometry, which support a linear correlation between the variables in both, absolute values and ratios. Intraclass correlation coefficient was calculated for both, the venous glucose and glucometry ratios, which was 0.52, revealing a moderate agreement among the tests. Sensitivity and specificity of CSF glucose/glucometry, as compared to gold standard are 73.1% and 60.6% respectively; whereas predictive positive value (PPV) and negative predictive value (NPV), were 40.4% and 86.0%.ConclusionGlucometry cannot replace the glucose in venous sample in the diagnosis of hypoglycorrhachia in children. 相似文献
73.
Lía Ornat Rebeca Martínez-Dearth Ana Muñoz Pilar Franco Benita Alonso Mauricio Tajada Faustino R. Pérez-López 《Maturitas》2013
Purpose
To assess sexual function, satisfaction with life (SWL), and menopause-related symptoms among mid-aged Spanish women.Materials and methods
Cross-sectional study of 260 women, aged 40–59, attending the public gynecology consultations completed the 14-item Changes in Sexual Functioning Questionnaire (CSFQ-14), the SWL Scale (SWLS), the Menopause Rating Scale (MRS), and a socio-demographic questionnaire.Results
Median [inter quartile range] age was 47 [8.0] years, 87.7% had a stable partner, 27.0% were postmenopausal, and 53.9% had increased body mass index (BMI). The prevalence of sexual dysfunction was 46.5% (CSFQ-14 score ≤ 41). Postmenopausal status was associated with lower CSFQ-14 scores (worse sexual function) and severe menopausal symptoms whereas there were not significant differences in SWLS scores. CSFQ-14 scores correlated with SWLS (p < 0.04), and inversely correlated with menopausal symptoms (p < 0.02). Multiple linear regression analysis model predicted 26.6% of the total CSFQ-14 score variance, and higher scores (better sexual function) were correlated with better SWL, and inversely correlated to female age and worse menopausal symptoms. A second model predicted 38.4% of the SWLS score variance. The SWLS score correlated with the total CSFQ-14 score and BMI, and inversely correlated with economical problems, female tobacco use, lack of healthiness, menopausal symptoms, not having a partner, and partner's lack of healthiness.Conclusions
Lower sexual function was related to low SWL, age and menopausal symptoms while low SWLS score was related with economical problems, smoking, menopausal symptoms, and partner factors. 相似文献74.
75.
Jorge Correale María E. Balbuena Aguirre Mauricio F. Farez 《Clinical immunology (Orlando, Fla.)》2013,149(2):176-181
Vitamin D status, smoking, and Epstein–Barr virus infection (EBV) may all contribute to explain differences in disease prevalence and incidence of Multiple Sclerosis (MS). MS affects women more often than men, and recent cross-sectional study assessments provide evidence of increased female to male prevalence in relapsing remitting MS patients, suggesting that sex hormones may exert an active role in disease pathogenesis. Studies in both humans and animal disease models demonstrate a functional synergy for the immunomodulatory effects of Vitamin D3 and 17-β estradiol. Both smoking and EBV infection clearly increase MS risk, and smoking history has also been associated with poorer disease prognosis. However, neither factor can explain the recent trend indicating greater female prevalence. Therefore, large population-based case–control studies from well defined geographic areas with homogeneous populations should be performed, in order to define environmental factor effects, and sex hormone influences, to better understand prevalence and incidence gender differences observed. 相似文献
76.
Joo Manoel Rossi Neto Antonio Sergio Tebexreni Alexandre Novakoski F. Alves Floriana Bertini Abreu Priscilla Ayumi Nishio Mauricio Cruz Thomazi Ivana Antelmi Paola Emanuela P. Smanio 《Arquivos brasileiros de cardiologia》2020,115(3):468
Background The most widely used data for cardiorespiratory fitness (CRF) referrals are from the Cooper Clinic, which uses calculated maximal oxygen uptake (VO2max) values.Objective To develop CRF values from cardiopulmonary exercise testing (CPX) in a Brazilian population with high socioeconomic level and free of structural heart disease. VO2max testing results were compared with the Cooper Clinic and FRIEND Registry data.Methods CPX data from consecutive individuals between January 1,2000, and May 31,2016 were used in this study. Inclusion criteria were: VO2max by a pre-specified definition. We built a CRF chart according to VO2max percentiles: very poor (≤20%), poor (20-40%), fair (40-60%), good (60-80%), excellent (80-90%), and superior (≥90%). Kappa correlation was used to analyze our data in comparison with that of the other two databases. Statistical tests with p<0.005 were considered significant.Results Final cohort included 18,186 tests: 12,552 men, 5,634 women (7–84 years). The most recurrent response was “good” (20.2%). There was a mean difference in weight, height, body mass index (BMI), and age in the CRF chart. An inverse correlation existed between VO2max and age, weight, and BMI. Using a linear regression and these variables, a predictive equation was developed for VO2max. Our findings differed from that of the other databases.Conclusion We developed a classification for CRF and found higher values in all classification ranges of functional capacity in contrast to the Cooper Clinic and FRIEND Registry. Our findings offer a more accurate interpretation of ACR in this large Brazilian population sample when compared to previous standards based on the estimated VO2max. (Arq Bras Cardiol. 2020; 115(3):468-477) 相似文献
77.
78.
79.
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. 总被引:9,自引:0,他引:9
Cristiana Vitale Mauricio Wajngaten Barbara Sposato Otavio Gebara Paola Rossini Massimo Fini Maurizio Volterrani Giuseppe M C Rosano 《European heart journal》2004,25(20):1814-1821
AIM: Elderly patients have an increased incidence of ischaemic dilated cardiomyopathy often related to diffuse coronary artery disease. Trimetazidine protects ischaemic myocardium by improving the myocardial energy utilisation during myocardial ischaemia. Aim of the present study was to evaluate the effects of trimetazidine on left ventricular (LV) function in elderly patients with ischaemic heart disease and reduced LV function. METHODS: Forty seven elderly patients (40 males and 7 females, mean age 78+/-3 years) were randomised to receive, in addition to standard therapy, either trimetazidine or placebo and were evaluated by echocardiography at baseline and after 6 months. RESULTS: Trimetazidine and placebo had no effect on either blood pressure or heart rate (SBP 2+/-5 vs 4+/-6 mmHg, DBP -1+/-6 vs 3+/-4 mmHg, HR -3+/-7 vs 5+/-9 bpm, trimetazidine and placebo compared to baseline, respectively). At the end of the study patients randomised to trimetazidine showed a significant greater left ventricular function and smaller left ventricular diastolic and systolic diameters and volume indices compared to patients receiving placebo (LVEF: 34.4+/-2.3% vs 27+/-2.8%, p<0.0001; LVEDD: 58.6+/-1.9 mm vs 64+/-1.7 mm, p<0.0001; LVESD: 44.5+/-1.1 vs 50+/-0.8 mm, p<0.0001). A significant smaller wall motion score index was detected in trimetazidine-treated patients compared to those allocated to placebo (1.24+/-0.12 vs 1.45+/-0.19, p<0.01), the percentage change in LVEF compared to baseline was also significantly greater in trimetazidine-treated patients. Diastolic function significantly improved in the trimetazidine group while it remained unchanged in the placebo group. At follow-up evaluation, patients receiving trimetazidine showed a greater improvement in angina and NYHA class than patients allocated to placebo. Quality of life significantly improved in all patients treated with trimetazidine while remained unchanged in those allocated to placebo. CONCLUSION: In elderly patients with ischaemic cardiomyopathy trimetazidine in addition to standard medical therapy has a beneficial effect on LV systolic and diastolic function, and improves quality of life. 相似文献
80.
Clinical efficacy of amiodarone as an antiarrhythmic agent 总被引:28,自引:0,他引:28
Mauricio B. Rosenbaum MD FACC Pablo A. Chiale MD M.Susana Halpern MD Gerardo J. Nau MD Julio Przybylski MD Raúl J. Levi MD Julio O. Lzzari MD Marcelo V. Elizari MD FACC 《The American journal of cardiology》1976,38(7):934-944
Amiodarone, administered orally in doses of 200 to 600 mg/day, was remarkably effective in the treatment and prevention of a wide variety of atrial and ventricular arrhythmias. Total suppression and control was provided in 98 (92.4 percent) of 106 patients with supraventricular arrhythmias and in 119 (82 percent) of 145 patients with ventricular arrhythmias. The rates of total control of the arrhythmia were: 96.6 percent in 30 patients with recurrent atrial flutter or fibrillation, 96.6 percent in 59 patients with repetitive supraventricular tachycardia, 100 percent in 27 patients with Wolff-Parkinson-White syndrome and 77.2 percent in 44 patients with recurrent ventricular tachycardia unsuccessfully treated with other drugs. Excellent results were obtained in 6 of 8 patients with repetitive ventricular tachycardia and ventricular fibrillation related to postinfarction ventricular aneurysm and in 12 of 14 patients with ventricular extrasystoles and ventricular tachycardia related to Chagasic myocarditis. Amiodarone proved safe in patients with severe congestive heart failure and severe myocardial damage. Its clinical efficacy was related to its electrophysiologic properties and to two unique properties: its wide safety margin and its cumulative effect. The latter liberates patients from a rigid hourly schedule and provides for continuous antiarrhythmic control, days and even weeks after treatment is discontinued. 相似文献